ArticleLife science alliance2026
A potential mechanism for tetraspanin CD82-mediated regulation of EGFR.
Article in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epidermal growth factor receptor (EGFR) regulates cell growth, differentiation, and migration through mechanisms of ligand binding and dimerization. Tetraspanin CD82 is known to interact with and regulate EGFR; however, the underlying molecular mechanisms are not clear. In this study, we used detergent-solubilized and detergent-purified EGFR-CD82 complexes and fusion proteins to characterize the interaction of EGFR with CD82 by size-exclusion chromatography and cryo-electron microscopy. Our data show that CD82 binds monomeric EGFR and dissociates from EGFR dimers. Congruently, less EGF is bound to EGFR in the presence of CD82, likely because of reduced EGFR dimerization. AlphaFold2 multimer predictions together with a 15 Å resolution cryo-EM density map support a curved-back conformation of EGFR with a putative interaction site between monomeric EGFR domain IV and the large extracellular loop of CD82. Together, our results support CD82 regulating EGFR function by hindering dimer formation and show CD82 dissociation from EGFR upon EGF-induced EGFR dimerization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.